Monte Rosa Therapeutics to Present at Upcoming Investor
BOSTON, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company
Globe Newswire3-02-2023, 19:36
King Faisal Specialist Hospital and Research Centre Celebrates the Success of Treating 100 Patients with Lymphocytic Leukemia Using CAR T-Cells 30-10-2023, 22:14